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OBJECTIVE: To evaluate the recent scientific research progress on homeopathy.
METHODOLOGY: Homeopathy was evaluated in terms of its clinical research; in vitro research, and physical
foundations. The Medline database was the main reference source for the present research, concerning data of approximately
the last 10 years. Secondary references (not available in this database) were obtained by means of direct requests to authors
listed in the primary references.
RESULTS: Clinical studies and in vitro research indicate the inefficacy of homeopathy. Some few studies with positive
results are questionable because of problems with the quality and lack of appropriate experimental controls in these studies.
The most recent meta-analyses on the topic yielded negative results. One of the few previous meta-analyses with positive
results had serious publication bias problems, and its results were later substantially reconsidered by the main authors. The
sparse in vitro homeopathic research with positive results has not been replicated by independent researchers, had serious
methodological flaws, or when replicated, did not confirm the initial positive results. A plausible mechanism for homeopathic
action is still nonexistent, and its formulation, by now, seems highly unlikely.
CONCLUSIONS: As a result of the recent scientific research on homeopathy, it can be concluded that ample evidence
exists to show that the homeopathic therapy is not scientifically justifiable.
DESCRIPTORS: Homeopathy. Complementary and alternative medicine. Pseudo-science.
Homeopathy, introduced by the
German physician Samuel
Hahnemann at the beginning of the
19th century, consists of the treatment
of the symptoms of a disease by means
of ultra-diluted substances. These sub-
stances are chosen based on the as-
sumption that they would cause the
same symptoms in healthy subjects if
ingested in measurable amounts. Min-
erals, vegetables, or substances ob-
tained from living organisms may be
used in the preparation of homeo-
pathic medicines. Supposedly, the ef-
fect of these substances becomes
stronger the more they are diluted. An
important step in their preparation is
called the succussion: “shakes” that are
applied to the substance after each di-
lution stage. Although mostly recom-
mended for small afflictions, some-
times radical statements about the ef-
fectiveness of homeopathy are made,
for instance, concerning the treatment
of AIDS1.
In Brazil, homeopathy is accepted
as a medical, pharmaceutical, and vet-
erinary specialty. Homeopathy also
has an accepted medical status in Eng-
land, India, and some States of the
United States (Arizona, Connecticut,
and Nevada), and its use is widespread
in many other countries2. The amount
of research on homeopathic topics rose
substantially in the last 20 years. The
analysis of its scientific status, there-
fore, can already take into account a
large number of studies, and such an
analysis is obviously important, both
in terms of general scientific advance-
ment and for health financing reasons.
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The objective of the present study
was to critically review and assess the
current scientific status of homeo-
pathic medicine. This review focused
on the performance of homeopathy in
clinical trials, on its state-of-the-art in
basic research, and on its physical
foundations. References were basi-
cally obtained with the help of the
Medline-Pubmed database and were
restricted to (approximately) the last
10 years. Secondary references, not
available in this database, were also
identified by means of direct contact
with primary authors.
Clinical trials
Probably the best strategy for as-
sessing the effect of homeopathy is
through the results of its clinical tri-
als. Many good quality studies of the
last 12 years have yielded negative re-
sults, for instance, concerning system-
atic reviews and meta-analyses3-11; in-
fections of the upper respiratory tract
and allergic rhinitis12,13; post-operative
ileus14; asthma15; warts16-18; pain relief
and muscle soreness19-23; treatment of
adenoid vegetation24; chronic head-
ache25-28; ear inflammation29,30; ec-
zema31; arthritis32,33; bruising34,35; anxi-
ety36; “provings” (see below) with bel-
ladonna, arnica, Pulsatilla and mer-
cury37-41 and “aggravations” (“good”
worsening of symptoms, said by
homeopaths to precede patient recov-
ery)42.
Detailed comments on many of
these studies are published2,5,43. Some
studies were at first considered to be
of good methodological quality, in
which positive results were found,
concerning, for example, allergic rhini-
tis and childhood diarrhea44,45. These
studies, however, could not be inde-
pendently replicated13,46, and some
methodological flaws were later de-
tected in their designs47,48. The present
review could not identify any homeo-
pathic clinical trial that was positively
replicated by an independent
group49,50.
In 1990, Hill and Doyon3 reviewed
40 randomized double-blind studies,
and concluded that “The results do not
provide acceptable evidence that ho-
meopathic treatments are effective”. In
a review of the scientific literature con-
cerning pediatric homeopathy, Kurz4
concluded that “The review of studies
carried out according to current sci-
entific criteria revealed—-at best—a
placebo effect of homeopathy”. Linde
and Melchart6, in a review of homeo-
pathic studies on “individualized ho-
meopathy” (one of the current schools
of homeopathic treatment), stated that
“…when the analysis was restricted to
the methodologically best trials no
significant effect was seen”. Ernst and
Pittler7 in a review of the scientific lit-
erature on the homeopathic prepara-
tion - arnica, concluded that “The
claim that homeopathic arnica is effi-
cacious beyond a placebo effect is not
supported by rigorous clinical trials”.
One of these authors, in another re-
view8, states: “It is concluded that the
trial data available to date do not
suggest that homeopathy is effective
in the prophylaxis of migraine or head-
ache beyond a placebo effect”, and,
more recently10, that: “…(in this re-
view) there was no condition which
responds convincingly better to ho-
meopathic treatment than to pla-
cebo…”.
In 1991, Kleijnen et al. published
a meta-analysis51 that reported a small
positive effect for homeopathic treat-
ments. However, the authors empha-
sized the fact that clear conclusions
were not feasible, since most studies
had a very low methodological qual-
ity, which could severely bias the re-
sults. Similarly, Linde et al.49, in a 1997
review of more than 100 studies, iden-
tified a favorable result for homeopa-
thy. Also in this case, however, the au-
thors admitted that publication bias
could introduce an effect that was “dif-
ficult to estimate”. In addition, they
stated that: “…we found little evi-
dence of effectiveness of any single
homeopathic approach on any single
clinical condition”.
The magnitude of the bias and the
quality of the studies in these reviews
is illustrated by a positive study that,
when re-assessed, actually revealed no
effect of homeopathy over placebo
(the original analysis used an inad-
equate statistical methodology). How-
ever, the inadequate study was still ac-
cepted in these reviews and consid-
ered to be of good quality53,54. Simi-
larly, the French government commis-
sioned a high-quality trial with the ob-
jective of confirming (or not) 2 prelimi-
nary positive homeopathic studies of
poor quality. This new trial did not
yield any positive results, but all 3
studies were included in the reviews55.
Moreover, the presence of bias was
later confirmed56-58, by means of a
visual test that allowed for the identi-
fication of a publication bias in the
“positive studies” direction. Another
approach was the reproduction of the
analysis of Linde et al., but taking into
account only those studies judged to
be of the highest quality59. The con-
clusion of this new analysis was that:
“…homeopathic remedies are associ-
ated with the same clinical effect as
placebo” and that: “… applying strict
criteria, a meta-analysis of dilute ho-
meopathic remedies shows no effect
over placebo whatsoever” 59.
Also, in a re-assessment of their
work60,61, the main authors of the 1997
review stated that: “…there was clear
evidence that [homeopathic] studies
with better methodological quality
tended to yield less positive results”,
and that: ”The evidence of bias weak-
ens the findings of our original meta-
analysis… It seems, therefore, likely
that our meta-analysis at least over-
estimated the effects of homeopathic
treatments”.
Finally, 2 other recent reviews11,62
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concluded that no effect can be de-
tected when studies of better methodo-
logical quality are considered, and still
another, specifically dealing with the
post-operative ileus condition63, found
negative results for the studies in
which homeopathic preparations had
been highly diluted.
As can be seen, the relationship be-
tween the lack of quality in a homeo-
pathic study and its positive results
arises in numerous studies, and some
authors repeatedly warn against the
fact that “alternative and complemen-
tary” medical journals create a serious
publication bias in the field64. Thus,
the message that consistently emerges
is that homeopathic studies with posi-
tive results are those of low methodo-
logical quality, in which double-blind
characteristics could not be assured,
that had statistical methodological
flaws or that were published in less rig-
orous journals54-67. For instance, in the
study mentioned by Linde et al., only
20% of the trials could actually be
considered as “blind”67.
In addition, other reasons for posi-
tive results can be noted:
- homeopathic preparations with a
relatively low dilution may still retain
pharmacological properties68. Even if
these effects were not specific for the
problem being addressed, the masking
of the “intervention” group could be
thus compromised.
- There are documented cases in
which homeopathic medications had
been adulterated69-71. For instance, Kerr
and Saryan69, in an analysis of homeo-
pathic preparations in the United
States, found arsenic in 2 out of 6
tested samples. Also, in a recent review
120 samples of “alternative medicine”
medications (including homeopathy),
Gupta et al.71, in India, found that 38%
of them were contaminated with
corticosteroids. An older study in the
United States70 detected a similar pro-
portion.
Another homeopathic research
topic that has yielded fully negative
results is the one of “homeopathic
provings”37-41. This is a fundamental
procedure for the definition of homeo-
pathic prescriptions. In these provings,
arbitrary substances are given to a
small number of healthy volunteers,
and the subsequent symptoms are re-
corded by the volunteers. As men-
tioned, homeopathic prescriptions are
then developed from the assumptions
that these substances, ultra-diluted,
could cure these same symptoms in
sick subjects. For instance, in a recent
experiment that tried to submit these
assumptions to a double-blind test38,
47 volunteers were divided in 2
groups, one receiving a placebo, and
the other, ultra-diluted belladonna. It
was not possible to observe any dis-
cernible pattern in the symptoms re-
ported by the 2 groups. Another inter-
esting older example concerns an ex-
periment on homeopathic Pulsatilla40
in which subjects received either a pla-
cebo or the homeopathic preparation
in a cross-over design. No differences
could be detected between the 2
groups, and an interesting result was
that during the first month, clear symp-
toms were reported by all patients,
probably due to the “novelty” charac-
teristic of the study.
Physical foundations and in vitro re-
search
The modern in vitro homeopathic
research can be said to begin with the
work of the French immunologist
Jacques Benveniste, during the 1980s.
In 1988, this researcher reported that
in his laboratory, conclusive proof of
homeopathic effects had been identi-
fied. According to him, water could re-
tain a “memory” of its solutes and, with
this memory, cause the degranulation
of basophil cells in vitro, even after the
solute had been diluted to 10-120.
Benveniste´s study72 was accepted
for publication in the Nature journal,
as long as a committee, assigned by
the journal, could make an in loco
replication attempt. This committee,
however, concluded that73:
- the experiments were not double-
blind;
- they “worked better” when per-
formed by a specific member of
Benveniste´s team;
- when the experiments did not work,
they were discarded;
- no adequate statistical control
methods were employed;
- when replicated with better con-
trols, no effect could be detected.
In summary, “…an extensive series
of experiments which are statistically
ill-controlled, from which no substan-
tial effort has been made to exclude
systematic error, including observer
bias, and whose interpretation has
been clouded by the exclusion of meas-
ures in conflict with the claim…”.
Recently, an allegedly positive
replication of this study was re-
ported74. This new experiment was per-
formed in 4 European laboratories, and
a member of Benveniste´s original
team took part in them. This study,
however, was only published as a short,
non-peer reviewed article, and, appar-
ently, had methodological flaws that
could compromise its results. For in-
stance, the authors reported that ¼ of
their data had to be discarded, al-
though no clear justification was pre-
sented for that. Also, the statistical
techniques used appear inadequate.
For instance, consider the fractions of
control x treatment degranulation re-
ported in the study for “laboratory 1”:
“Laboratory Control Histamine number F p
(% degranulation) (% degranulation)
1 45.8 36.5 123 15.35 .0002”
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Using standard statistical formulae
for a 2-proportions t-test75, one finds a
95% Confidence Interval of:
95% CI lab 1: [-0.03; 0.21] ; not
statistically significant.
Finally, at least 5 other research
groups tried to replicate Benveniste´s
results, not one of them finding a posi-
tive effect76-80.
More recently, Benveniste stated
that the “homeopathic potentialization”
of a substance could be sent and recov-
ered through electromagnetic means
(for example, through an e-mail mes-
sage)81. The “water memory” thus digi-
tized could then be used to transfer the
properties of the original solute to other
substances, at long distance. More in-
formation on this (still non-substanti-
ated) claim can be found in <http://
www.digibio.com>.
Currently, research in this area still
continues, basically coordinated by an
international consortium named GIRI
(International Research Group on
Very Low Dose and High Dilution Ef-
fects, in French). The member list of
this group has more than 150 scientists
from many countries, and renowned
members include the French immu-
nologist Madeleine Bastide. In one of
the few studies of the group that ap-
peared in the scientific literature82,83,
the authors attempted to study the ef-
fects of ultra-diluted thyroxine (10-60)
in the growth of juvenile frogs (see
Endler84 for more details). The authors
report on the results of 4 experiments.
In the first one, a very highly diluted
thyroxine solution was applied to a
tank in which juvenile frogs were de-
veloping. In the second, this solution
was placed inside a sealed vial, which
was then placed close to the tank
(without contact with the water). In 2
other experiments, a procedure was
used to “digitize” the properties of the
solution and then to “communicate”
them to water in another vial. Basically,
in the 2 last experiments, a vial with
the thyroxine preparation was con-
nected to a coil wire and to an ampli-
fier. An electric current was then ap-
plied to the wire, and “after filtering
and noise reduction”, the homeo-
pathic effect was, allegedly, transferred
to a pure water vial, also connected to
the amplifier. In each of the 4 experi-
ments, “diluted water (water 10-60)”
was used as control. Results were simi-
lar in all the 4 experiments: frog
growth was altered whether they were
exposed to the ultra-diluted thyroxine,
to the closely placed sealed vial, or to
the vials to which the “digitized”
properties had been transferred. The
authors also reported that many other
factors, for instance, the time of the
year when the experiments were per-
formed, appeared to influence the re-
sults.
From these experiments, the au-
thors concluded that the homeopathic
effect propagates through electromag-
netic waves, which had transferred the
homeopathic effect to the frogs. How-
ever, the most probable explanation is
that the complex and non-blind char-
acteristic of the work allowed for the
introduction of bias, which would ex-
plain the altered rate of growth in all
4 experiments85,86.
Other GIRI members further ex-
panded the implications of these re-
sults. For instance, the Belgian re-
searcher William Betz reports that, in
a similar situation, when both a pla-
cebo and a homeopathic preparation
produced the same effect, Madeleine
Bastide concluded that the placebo
had been “contaminated” by the “ho-
meopathic radiation”, arising from the
closely stored homeopathic prepara-
tion85.
Finally, Vickers87 performed a com-
prehensive review of the literature con-
cerning “pre-clinical research” in ho-
meopathy, concluding that: “There is
a lack of independent replication of
any pre-clinical research in homoe-
opathy. In the few instances where a
research team has set out to replicate
the work of another, either the results
were negative or the methodology was
questionable” .
In summary, similarly to the analy-
sis concerning clinical trials, here,
also, it is possible to identify a clear
relationship between the low methodo-
logical quality of a homeopathic study
and its positive results.
Still concerning the physical
mechanisms of homeopathy, it is not
possible to identify differences be-
tween homeopathic preparations and
pure water by means of a nuclear mag-
netic ressonance (NMR) analysis88. It
is well known that homeopathy “vio-
lates” the Avogadro number, that is, in
a homeopathic preparation above a 10-
24 dilution, not 1 molecule of the origi-
nal solute is expected to be found.
However, explanations for the putative
action mechanisms for homeopathy
under these circumstances are only
very rarely presented. Worse yet, when
examined, these few explanations turn
out to be absolutely non-substantiated
and non-scientific43,86. For instance, in
a recent introduction to homeopathy
in the British Medical Journal89, the
authors made the (non-referenced)
statement that “The complex lattice
formations created by water molecules
are thought by some to hold the key
to … homeopathy”. The reason for
such an oblique, unspecific citation
must be the long history of non-cor-
roborated search for such water struc-
tures, of which a recent example is Lo
et al.90-92.
It should also be noticed that this
low concern with a possible mecha-
nism of action leaves unanswered ar-
guments such as93: “It is estimated that
in 60 seconds a person standing still
generates about 100 000 particles –
skin fragments, salt, oil droplets, hu-
midity and cosmetics – which are large
enough to damage an integrated cir-
cuit during its manufacturing process.
Even if homeopathic medications were
prepared in a room of maximum clean-
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ness, the chance of one of these parti-
cles ending in the final preparation
would be large. How could the water
tell between what is the active sub-
stance and what is a sulphur molecule
from a hairspray? How can it tell, in
its memory, the molecule of the rotten
liver of a duck among millions of or-
ganic particles that are thrown over
it by the simple act of breathing?”
CONCLUSIONS
The statement that homeopathy is
“discriminated by an “official science”
cannot be supported by the results of
the present review. The quantity and
quality of the current research in this
area indicates that, actually, the rejec-
tion of homeopathy as a valid scien-
tific endeavor comes from the fact that
the more recent research has thor-
oughly disconfirmed the main homeo-
pathic hypotheses. Another conclusion
concerns the relationship between the
quality of a homeopathic study and its
positive results. This is a clearly rec-
ognized phenomenon, which, for in-
stance, admittedly “contaminated” the
meta-analyses conducted in the 1990s
that detected a (weak) favorable effect
for homeopathic preparations.
In summary, the present review in-
dicates that the weight of the modern
evidence clearly disconfirms the hy-
pothesis that ultra-diluted substances
could have a noticeable clinical or
pharmacological effect in living or-
ganisms.
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RESUMO
ALMEIDA RMVR - Uma revisão crí-
tica da literatura relativa aos pos-
síveis benefícios da medicina ho-
meopática. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58(6):324-331,
2003.
OBJETIVOS: Avaliar os resultados
da pesquisa científica em relação aos
possíveis benefícios da homeopatia.
METODOLOGIA: A homeopatia
foi avaliada a partir de sua pesquisa
clínica; sua pesquisa in vitro ou “pré-
clínica” e seus fundamentos físicos.
Para tal, foi realizada uma ampla revi-
são e análise crítica da literatura cien-
tífica mais recente no tópico. (aproxi-
madamente últimos dez anos). Os tra-
balhos foram selecionados primeira-
mente a partir da base de dados
Medline. Referências secundárias (não
indexadas nesta base de dados) pude-
ram então ser obtidas por meio de con-
tato direto com autores listados nas re-
ferências primárias.
RESULTADOS: Tanto estudos clí-
nicos quanto pesquisas in vitro e estu-
dos de “provas” homeopáticas apon-
tam para a ineficácia de sua utilização.
Alguns poucos estudos com resultados
positivos podem ser explicados por
problemas de qualidade e (falta de)
controles adequados. As meta-análises
mais importantes na área forneceram
resultados negativos. Uma recente
meta-análise com resultados positivos
teve sérios problemas metodológicos,
e seus resultados foram, posteriormen-
te, substancialmente alterados pelos
autores. A pesquisa metodológica in
vitro, similarmente, apresenta poucos
resultados positivos, os quais possuem
sérios problemas metodológicos e não
puderam ser replicados por pesquisa-
dores independentes. Um mecanismo
plausível para a atuação das substân-
cias homeopáticas é inexistente, e sua
formulação, atualmente é altamente
improvável.
CONCLUSÃO: Como resultado
das pesquisas realizadas nos últimos
anos, podemos concluir que existe am-
pla evidência de que a prática homeo-
pática não é cientificamente justificá-
vel.
DESCRITORES: Homeopatia.
Medicina complementar e alternati-
va. Pseudo-ciência.
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